Does tramadol have a place in the dental armamentarium? An atypical opioid in dental practice from the pharmacological perspective – Part I. General tramadol administration

Marcin Pasternak

Abstract


Pain is common in dental practice. It is not only a reason for patients seeking dental treatment, but it can also accompany performed procedures and often occurs after them. The management of acute pain consists of causative treatment and pharmacotherapy, with non-steroidal anti-inflammatory drugs (NSAIDs) being the drugs of choice in routine dental practice. These agents, however, may not be potent enough in cases with, pain of greater intensity. This paper focuses on tramadol, an atypical opioid, which is the most popular analgesic of this type in the world and can be considered a valuable option for the management of moderate to severe pain in dentistry and oral surgery. The characteristics of the agent were described, as well as its singular mechanism of action and biotransformation. Adverse effects that can occur during tramadol pharmacotherapy were discussed together with interactions significant in clinical practice. The available tramadol formulations were presented, with particular attention to the drug combinations examined in pain management in a dental setting.

Keywords


tramadol; pain management; dental pain; dentistry; oral surgery

Full Text:

PDF

References


Thota L, Bansal R, Thota G, Chikkanna MK, Shanab H, Kumari VV. Efficacy of routinely used analgesics in management of pulpal pain postoperatively a clinical study. J Pharm Bioallied Sci 2021;13(Suppl 1):S684-7.

Pasternak M, Woroń J. Ostry ból endodontyczny. Ból 2020;21(1):39-45.

Pasternak M, Woroń J. Postępowanie w bólu poekstrakcyjnym. Ból 2020;21(1):47-52.

Pergolizzi JV, Magnusson P, LeQuang JA, Gharibo C, Varrassi G. The pharmacological management of dental pain. Expert Opin Pharmacother 2020;21(5):591-601.

Pasternak M, Woroń J. Rola znieczulenia miejscowego w uśmierzaniu bólu śródzabiegowego w praktyce stomatologicznej. Ból 2021;22(1):24-35.

Jakubów P, Branko J. Leczenie bólu w stomatologii. In: Jabłecka A, Krzemiński TF, editors. Podstawy farmakologii klinicznej, alergie, interakcje leków oraz wybrane problemy w stomatologii. Lublin: Czelej; 2005. p. 75-96.

Singgih MF, Huldani, Achmad H, Sukmana BI, Carmelita AB, Putra AP, et al. A review of nonsteroidal anti-inflammatory drugs (NSAIDs) medications in dentistry: uses and side effects. Sys Rev Pharm 2020;11(5):293-8.

Hachimi-Idrissi S, Dobiáš V, Hautz WE, Leach R, Sauter TC, Sforzi I, et al. Approaching acute pain in emergency settings; European Society for Emergency Medicine (EUSEM) guidelines – part 2: management and recommendations. Intern Emerg Med 2020;15(7):1141-55.

Mutschler E, Geisslinger G, Kroemer HK, Ruth P, Schäfer-Korting M. Analgetyki (leki przeciwbólowe). In: Mutschler E, Geisslinger G, Kroemer HK, Ruth P, Schäfer-Korting M. Mutschler. Farmakologia i toksykologia. Podręcznik. 2nd ed. Wrocław: MedPharm Polska; 2010. p. 217-88.

Kaczmarzyk T, Goszcz A, Grodzińska L, Stypułkowska J, Woroń J, Zaleska M. Farmakoterapia bólu w chirurgii stomatologicznej i szczękowo-twarzowej. In: Kaczmarzyk T, Goszcz A, Grodzińska L, Stypułkowska J, Woroń J, Zaleska M. Współczesna farmakoterapia w schorzeniach chirurgicznych jamy ustnej i tkanek okolicznych. Kraków: Wydawnictwo Uniwersytetu Jagiellońskiego; 2006. p. 171-213.

Bravo L, Mico JA, Berrocoso E. Discovery and development of tramadol for the treatment of pain. Expert Opin Drug Discov 2017;12(12):1281-91.

WHO model list of essential medicines. Geneva: World Health Organization; 2017.

Woroń J, Korbut R. Ambulatoryjne leczenie tramadolem – spojrzenie farmakologa. Gal Gaz Lek 2020;4:21-2.

Donaldson M, Goodchild JH. Tramadol: what have we learned in the last 25 years? Gen Dent 2021;69(4):14-8.

Shipton EA. Tramadol – present and future. Anaesth Intensive Care 2000;28(4):363-74.

Barakat A. Revisiting tramadol: a multi-modal agent for pain management. CNS Drugs 2019;33(5):481-501.

Cillo JE. Peri-operative pain management in maxillofacial surgery. In: Ferneini E, Bennett JD, editors. Perioperative assessment of the maxillofacial surgery patient. Cham: Springer; 2018. p.145-60. doi: 10.1007/978-3-319-58868-1_11.

Dobrogowski J, Wordliczek J, Woroń J. Opioidowe leki przeciwbólowe w farmakoterapii bólu. In: Dobrogowski J, Wordliczek J, Woroń J, editors. Farmakoterapia bólu. Poznań: Termedia Wydawnictwa Medyczne; 2014. p. 61-104.

Schumacher MA, Basbaum AJ, Naidu RK. Opioid agonists & antagonists. In: Katzung BG, Trevor AJ, editors. Basic & clinical pharmacology. 13th ed. San Francisco: McGraw-Hill Education; 2015, p. 531-51.

Schuh CM, Bens B, Aguayo S. Potential novel strategies for the treatment of dental pulp-derived pain: pharmacological approaches and beyond. Front Pharmacol 2019;10:1068.

Olszanecki R. Immunofarmakologia. In: Olszanecki R, Wołkow P, Jawień J. Farmakologia. 2nd ed. Warszawa: PZWL Wydawnictwo Lekarskie; 2019. p. 184-210.

Saeed I, La Caze A, Hollmann MW, Shaw PN, Parat MO. New insights on tramadol and immunomodulation. Curr Oncol Rep 2021;23(11):123.

Raffa RB, Friderichs E, Reimann W, Shank RP, Codd EE, Vaught JL, et al. Complementary and synergistic antinociceptive interaction between the enantiomers of tramadol. J Pharmacol Exp Ther 1993;267(1):331-40.

Minami K, Sudo Y, Miyano K, Murphy RS, Uezono Y. µ-Opioid receptor activation by tramadol and O-desmethyltramadol (M1). J Anesth 2015;29(3):475-9.

Zebala JA, Searle SL, Webster LR, Johnson MS, Schuler AD, Maeda DY, et al. Desmetramadol has the safety and analgesic profile of tramadol without its metabolic liabilities: Consecutive randomized, double-blind, placebo-and active comparator-controlled trials. J Pain 2019;20(10):1218-35.

Ogbemudia B, Qu G, Henson C, Esfandiary L, Przkora R, Victor S. Tramadol use in perioperative care and current controversies. Curr Pain Headache Rep 2022;26(3):241-6.

Nakhaee S, Hoyte C, Dart RC, Askari M, Lamarine RJ, Mehrpour O. A review on tramadol toxicity: mechanism of action, clinical presentation, and treatment. Forensic Toxicol 2021;39(2):293-310.

Subrahmanyam V, Renwick AB, Walters DG, Young PJ, Price RJ, Tonelli AP, et al. Identification of cytochrome P-450 isoforms responsible for cis-tramadol metabolism in human liver microsomes. Drug Metab Dispos 2001;29(8):1146-55.

Saiz-Rodríguez M, Valdez-Acosta S, Borobia AM, Burgueño M, Gálvez-Múgica MÁ, Acero J, et al. Influence of genetic polymorphisms on the response to tramadol, ibuprofen, and the combination in patients with moderate to severe pain after dental surgery. Clin Ther 2021;43(5):e86-e102.

Terman G. Is Tramadol an Opioid or a Nonopioid Analgesic? Yes! Update! 2020;10. https://wmc.wa.gov/sites/default/files/public/Newsletter/IsTramadolanOpioid.pdf (14.12.202)

LLerena A, Naranjo MEG, Rodrigues-Soares F, Penas-LLedó EM, Fariñas H, Tarazona-Santos E. Interethnic variability of CYP2D6 alleles and of predicted and measured metabolic phenotypes across world populations. Expert Opin Drug Metab Toxicol 2014;10(11):1569-83.

Dhesi M, Maldonado KA, Maani CV. Tramadol. In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2022.

Hassabou NF, Elseweidy MM. Histopathological changes in submandibular gland and dorsal tongue of experimental rats due to prolonged tramadol intake focusing on novel modulatory effect of 10-dehydrogingerdione. Arch Oral Biol 2021;130:105223. doi: 10.1016/j.archoralbio.2021.105223.

World Health Organization. WHO Expert Committee on Drug Dependence: thirty-sixth report. WHO technical report series; No. 991. Geneva: World Health Organization; 2017, p. 45-6.

Cronin T, Smith LF. Tramadol-induced hypoglycaemia. Postgrad Med J 2018;94(1108):121. doi: 10.1136/postgradmedj-2017-135217.

Hassamal S, Miotto K, Dale W, Danovitch I. Tramadol: understanding the risk of serotonin syndrome and seizures. Am J Med 2018;131(11):1382--e1-1382.e6.

Stevens AJ, Woodman RJ, Owen H. The effect of ondansetron on the efficacy of postoperative tramadol: a systematic review and meta-analysis of a drug interaction. Anaesthesia 2015;70(2):209-18.

Beakley BD, Kaye AM, Kaye AD. Tramadol, pharmacology, side effects, and serotonin syndrome: a review. Pain Physician 2015;18(10):395-400.

Baldo BA, Rose MA. The anaesthetist, opioid analgesic drugs, and serotonin toxicity: a mechanistic and clinical review. Br J Anaesth 2020;124(1):44-62.

Bozkurt P. Use of tramadol in children. Paediatr Anaesth 2005;15(12);1041-7. doi: 10.1111/j.1460-9592.2005.01738.x.

Useful medications for oral conditions. In: American Academy of Pediatric Dentistry. The reference manual of pediatric dentistry. 2021-2022. Chicago (Ill): American Academy of Pediatric Dentistry; 2022. p. 612-8.

Médecins Sans Frontières. Essential drugs – practical guidelines. 2022. https://medicalguidelines.msf.org/sites/default/files/pdf/guideline-339-en-2022-12-15.pdf (15.12.2022).

U.S. Food and Drug Administration. Drug Safety Communication: FDA restricts use of prescription codeine pain and cough medicines and tramadol pain medicines in children; recommends against use in breastfeeding women. https://www.fda.gov/media/104268/download (14.12.2022).

Vazzana M, Andreani T, Fangueiro J, Faggio C, Silva C, Santini A, et al. Tramadol hydrochloride: pharmacokinetics, pharmacodynamics, adverse side effects, co-administration of drugs and new drug delivery systems. Biomed Pharmacother 2015;70:234-8.

le Roux PJ, Coetzee JF. Tramadol today. Curr Opin Anesthesiol 2000;13(4):457-61.

Elnaghy AM, Elshazli AH, Badr AE, Elsaka SE. Effect of preoperative tramadol, ibuprofen, ibuprofen/acetaminophen on the anaesthetic efficacy of inferior alveolar nerve block in patients with symptomatic irreversible pulpitis. Aust Endod J 2022. doi: 10.1111/aej.12642.

Mao J, Gold MS, Backonja MM. Combination drug therapy for chronic pain: a call for more clinical studies. J Pain 2011;12(2):157-66.

White PF. Multimodal analgesia: its role in preventing postoperative pain. Curr Opin Investig Drugs 2008;9(1):76-82.

Perez-Urizar J, Martínez-Rider R, Torres-Roque I, Garrocho-Rangel A, Pozos-Guillen A. Analgesic efficacy of lysine clonixinate plus tramadol versus tramadol in multiple doses following impacted third molar surgery. Int J Oral Maxillofac Surg 2014;43(3):348-54.

Elvir-Lazo OL, White PF. The role of multimodal analgesia in pain management after ambulatory surgery. Curr Opin Anaesthesiol 2010;23(6):697--703. doi: 10.1097/ACO.0b013e32833fad0a.

Medve RA, Wang J, Karim R. Tramadol and acetaminophen tablets for dental pain. Anesth Prog 2001;48(3):79-81.

Woroń J, Wordliczek J. Połączenie tramadolu z deksketoprofenem w praktyce klinicznej – postęp w leczeniu bólu. Lekarz POZ 2017;3(1):61-7.

Varrassi G, Hanna M, Macheras G, Montero A, Montes Perez A, Meissner W, et al. Multimodal analgesia in moderate-to-severe pain: a role for a new fixed combination of dexketoprofen and tramadol. Curr Med Res Opin 2017;33(6):1165-73. doi: 10.1080/03007995.2017.1310092.

Moore RA, Gay-Escoda C, Figueiredo R, Tóth-Bagi Z, Dietrich T, Milleri S, et al. Dexketoprofen/tramadol: randomised double-blind trial and confirmation of empirical theory of combination analgesics in acute pain. J Headache Pain 2015;16:541.

Fornasari D, Allegri M, Gerboni S, Fanelli G. A “novel” association to treat pain: tramadol/dexketoprofen. The first drug of a “new pharmacological class”. Acta Biomed 2017;88(1):17-24.

Hanna M, Montero A, Perrot S, Varrassi G. Tramadol/dexketoprofen analgesic efficacy compared with tramadol/paracetamol in moderate to severe postoperative acute pain: subgroup analysis of a randomized, double-blind, parallel group trial – DAVID study. Pain Ther 2021;10(1):485-503.

Doroschak AM, Bowles WR, Hargreaves KM. Evaluation of the combination of flurbiprofen and tramadol for management of endodontic pain. J Endod 1999;25(10):660-3.

El-Sharrawy EA, El-Hakim IE, Sameeh E. Attenuation of C-reactive protein increases after exodontia by tramadol and ibuprofen. Anesth Prog 2006;53(3):78-82.

Olszanecki R. Niesteroidowe leki przeciwzapalne. In: Olszanecki R, Wołkow P, Jawień J. Farmakologia. 2nd ed. Warszawa: PZWL Wydawnictwo Lekarskie; 2019. p. 156-66.

Almansa C, Mercè R, Tesson N, Farran J, Tomàs J, Plata-Salamán CR. Co-crystal of tramadol hydrochloride–celecoxib (CTC): a novel API–API co-crystal for the treatment of pain. Cryst Growth Des 2017;17(4):1884-92.

Gascon N, Almansa C, Merlos M, Miguel Vela J, Encina G, Morte A, et al. Co-crystal of tramadol-celecoxib: preclinical and clinical evaluation of a novel analgesic. Expert Opin Investig Drugs 2019;28(5):399-409.

Langford R, Morte A, Sust M, Cebrecos J, Vaqué A, Ortiz E, et al. Efficacy and safety of co-crystal of tramadol-celecoxib (CTC) in acute moderate-to-severe pain after abdominal hysterectomy: A randomized, double-blind, phase 3 trial (STARDOM2). Eur J Pain 2022;26(10):2083-96.

López-Cedrún J, Videla S, Burgueño M, Juárez I, Aboul-Hosn S, Martín--Granizo R, et al. Co-crystal of tramadol–celecoxib in patients with moderate to severe acute post-surgical oral pain: a dose-finding, randomised, double-blind, placebo-and active-controlled, multicentre, phase II trial. Drugs R D 2018;18(2):137-48.

Yengopal V. What’s new for the clinician? Excerpts from and summaries of recently published papers. S Afr Dent J 2020;75(4):214-7.

Saber A, Kassir AR, Naaman N, Mokbel N, Semaan LB, Dagher M. Comparison of the analgesic efficacy of two medications in patients receiving dental implants: a randomized controlled trial. Curr Res Dent 2021;12(1):71-6.




DOI: https://doi.org/10.21164/pomjlifesci.901

Copyright (c) 2023 Marcin Pasternak

License URL: https://creativecommons.org/licenses/by-nc-nd/3.0/pl/